Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Internet

HD KOREA SHIPBUILDING & OFFSHORE ENGINEERING and Construction Equipment Hit with 73.5 Million Won Fine for Personal Information Leak

Two affiliates of HD HYUNDAI Group were slapped with fines and penalties totaling approximately 70 million won following a personal information leak involving employees that occurred in March 2024. Th…
  • 2026-08-27 11:00:04
  • An Yu-ri
Internet

Com2uS Corporation’s ‘ZEUS CO., LTD.: God of Arrogance’ Tops Sales Charts on Both Major App Stores

“ZEUS CO., LTD.: God of Hubris,” a new MMORPG (massively multiplayer online role-playing game) published by Com2uS Corporation(078340)and developed by Averton, topped the sales charts on both of South…
  • 2026-08-27 10:52:55
  • An Yu-ri
Internet

Elite AI Team Assembled… SKT Declares Its Intent to Develop "Security AI" with a "Security All-Star Team"

(AI-generated image) SKTelecom(017670)has partnered with Upstage, major domestic cybersecurity firms, and academia to develop a specialized AI foundation model for national cybersecurity. The comp…
  • 2026-08-27 10:24:49
  • Han Kwangbeom
Internet

Naver Cloud and LG Corp. Take on 'Reader-Secure AI'… Full-Stack Technology as Their 'Hail Mary'

(AI-generated image) Naver (NAVER(035420)) Cloud has teamed up with LG CNS (#LG CNS) to bid for the "Development of a Cybersecurity-Specialized AI Foundation Model" project led by the Ministry of …
  • 2026-08-27 10:18:00
  • Han Kwangbeom
Technology

Rejuran Injected into My Face—Still Not Approved in the U.S.?

PharmaResearch(214450)is seeking U.S. Food and Drug Administration (FDA) medical device approval for its flagship product, “Rejuran,” but is expected to face significant hurdles before actually enteri…
  • 2026-08-27 09:51:01
  • KIM SAE-MI
Technology

SillaJen, Inc.’s ‘BAL0891’ Granted Orphan Drug Designation by the FDA… Expanding Beyond Solid Tumors to Blood Cancers

SillaJen, Inc.(215600)is expanding the development scope of its next-generation anticancer candidate “BAL0891” from solid tumors to blood cancers. Given that early signs of efficacy have been confirme…
  • 2026-08-27 09:28:02
  • KIM SAE-MI
Internet

Cafe24 Corp. Unveils Creator Commerce Strategy… Featuring "Group Buying King" Hwang Bu-jang and "Ssin-nim"

Cafe24 Corp.(042000)is sharing commerce success strategies with creators looking to convert content views and fan engagement into actual revenue. It provides practical know-how necessary for creators …
  • 2026-08-27 08:57:29
  • Lee So-Hyun
Technology

HLB innoVation Acquires HLB Cell… Secures a Domestic Footing in Cell Therapy

HLB innoVation(024850)is acquiring HLB Cell, a company specializing in cell and regenerative medicine. The plan is to expand its business scope into the Korean and Asian markets by adding a domestic R…
  • 2026-08-27 08:32:03
  • Minji Son
Technology

Seegene Inc., Whose 70% of Revenue Came from COVID-19 and Respiratory Diseases… Reduces ‘Winter Dependency’ Through GI and HPV Tests

Seegene ( Seegene Inc.(096530)), whose revenue was heavily concentrated in respiratory diagnostics during the COVID-19 pandemic, is now cultivating non-respiratory products—such as gastrointestinal (G…
  • 2026-08-27 08:32:02
  • NA EUN-KYUNG
Technology

Kim Nam-yong, CEO of Curiox: "More Order Contracts and Advance Payment Agreements with Global Companies Are Expected"

“We recently secured an equipment order worth 510 million won from a global pharmaceutical company in the cell and gene therapy (CGT) sector. We are currently in active discussions with more than 10 g…
  • 2026-08-27 08:31:02
  • Kim Seung-kwon
prev 51 52 53 54 55 56 57 58 59 60 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English